As of the latest Form 4 filed Jul 1, 2026.
What Processa Pharmaceuticals Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
5 different Processa Pharmaceuticals Inc insiders made open-market purchases in the last 30 days. When several insiders buy at once it’s a stronger, harder-to-explain-away signal than a single trade — how to read this.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 34 most recent filings for PCSA.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-01 | 2026-07-01 | Ng George K Chief Executive Officer | PPurchase | +3.06K | $1.93 | $5.90K | No | Form 4 ↗ |
| 2026-07-01 | 2026-06-30 | Guy Wendy Chief Administrative Officer | PPurchase | +2.44K | $1.93 | $4.70K | No | Form 4 ↗ |
| 2026-07-01 | 2026-06-30 | Lin Patrick Chief Business - Strategy Off | PPurchase | +2.11K | $1.93 | $4.06K | No | Form 4 ↗ |
| 2026-07-01 | 2026-06-30 | SKIBSTED RUSSELL Chief Financial Officer | PPurchase | +3.28K | $1.93 | $6.32K | No | Form 4 ↗ |
| 2026-07-01 | 2026-06-30 | Young David Pres. Research & Development | PPurchase | +2.53K | $1.93 | $4.88K | No | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | Yorke Justin W Director | MExercise | +203.00 | — | — | No | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | Pannu Geraldine Director | MExercise | +203.00 | — | — | No | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | Neal James R Director | MExercise | +203.00 | — | — | No | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | Baluch Khoso Director | MExercise | +203.00 | — | — | No | Form 4 ↗ |
| 2026-06-16 | 2026-06-15 | Young David Pres. Research & Development | PPurchase | +2.07K | $2.22 | $4.59K | No | Form 4 ↗ |
| 2026-06-16 | 2026-06-15 | SKIBSTED RUSSELL Chief Financial Officer | PPurchase | +2.65K | $2.22 | $5.89K | No | Form 4 ↗ |
| 2026-06-16 | 2026-06-15 | Ng George K Chief Executive Officer | PPurchase | +2.46K | $2.22 | $5.47K | No | Form 4 ↗ |
| 2026-06-16 | 2026-06-15 | Lin Patrick Chief Business - Strategy Off | PPurchase | +1.83K | $2.22 | $4.06K | No | Form 4 ↗ |
| 2026-06-16 | 2026-06-15 | Guy Wendy Chief Administrative Officer | PPurchase | +2.12K | $2.22 | $4.70K | No | Form 4 ↗ |
| 2026-05-01 | 2026-04-30 | Young David Pres. Research & Development | PPurchase | +1.71K | $2.69 | $4.59K | No | Form 4 ↗ |
| 2026-05-01 | 2026-04-30 | SKIBSTED RUSSELL Chief Financial Officer | PPurchase | +2.19K | $2.69 | $5.89K | No | Form 4 ↗ |
| 2026-05-01 | 2026-04-30 | Ng George K Chief Executive Officer | PPurchase | +2.03K | $2.69 | $5.47K | No | Form 4 ↗ |
| 2026-05-01 | 2026-04-30 | Lin Patrick Chief Business - Strategy Off | PPurchase | +1.51K | $2.69 | $4.06K | No | Form 4 ↗ |
| 2026-05-01 | 2026-04-30 | Guy Wendy Chief Administrative Officer | PPurchase | +1.75K | $2.69 | $4.70K | No | Form 4 ↗ |
| 2026-05-01 | 2026-04-30 | Bigora Sian Chief Development Officer | PPurchase | +1.99K | $2.69 | $5.34K | No | Form 4 ↗ |
| 2026-04-17 | 2026-04-15 | Young David Pres. Research & Development | PPurchase | +1.54K | $2.97 | $4.59K | No | Form 4 ↗ |
| 2026-04-17 | 2026-04-15 | Ng George K Chief Executive Officer | PPurchase | +1.84K | $2.97 | $5.47K | No | Form 4 ↗ |
| 2026-04-17 | 2026-04-15 | Lin Patrick Chief Business - Strategy Off | PPurchase | +1.37K | $2.97 | $4.07K | No | Form 4 ↗ |
| 2026-04-17 | 2026-04-15 | Guy Wendy Chief Administrative Officer | PPurchase | +1.58K | $2.97 | $4.70K | No | Form 4 ↗ |
| 2026-04-17 | 2026-04-15 | Bigora Sian Chief Development Officer | PPurchase | +1.80K | $2.97 | $5.34K | No | Form 4 ↗ |
| 2026-04-17 | 2026-04-15 | SKIBSTED RUSSELL Chief Financial Officer | PPurchase | +1.98K | $2.97 | $5.89K | No | Form 4 ↗ |
| 2026-04-01 | 2026-03-31 | Young David Pres. Research & Development | PPurchase | +1.81K | $2.54 | $4.59K | No | Form 4 ↗ |
| 2026-04-01 | 2026-03-31 | SKIBSTED RUSSELL Chief Financial Officer | PPurchase | +2.32K | $2.54 | $5.89K | No | Form 4 ↗ |
| 2026-04-01 | 2026-03-31 | Pannu Geraldine Director | PPurchase | +2.07K | $2.54 | $5.25K | No | Form 4 ↗ |
| 2026-04-01 | 2026-03-31 | Ng George K Chief Executive Officer | PPurchase | +2.14K | $2.54 | $5.41K | No | Form 4 ↗ |
| 2026-04-01 | 2026-03-31 | Lin Patrick Chief Business - Strategy Off | PPurchase | +1.60K | $2.54 | $4.06K | No | Form 4 ↗ |
| 2026-04-01 | 2026-03-31 | Guy Wendy Chief Administrative Officer | PPurchase | +1.85K | $2.54 | $4.70K | No | Form 4 ↗ |
| 2026-04-01 | 2026-03-31 | Bigora Sian Chief Development Officer | PPurchase | +2.11K | $2.54 | $5.34K | No | Form 4 ↗ |
| 2026-04-01 | 2026-03-31 | Baluch Khoso Director | PPurchase | +2.27K | $2.54 | $5.75K | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also PCSA’s full analysis or the market-wide insider trading feed. The tabs above jump to PCSA’s other SEC data.
Source: SEC Form 4 filings for PCSA, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.